Evaluation of Sinetrol® Xpur in Fat Mass Reduction on Overweight and Obese Subjects
1 other identifier
interventional
77
1 country
1
Brief Summary
This study aims to evaluate effects of a 16-week supplementation with a polyphenol rich extract, Sinetrol® Xpur, on fat mass accumulation and body weight management improvement.Subjects were overweight or obese and received polyphenol supplement or placebo. A 4-week follow-up as performed to evaluate its effect after supplementation stop.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
October 31, 2019
CompletedFirst Posted
Study publicly available on registry
November 4, 2019
CompletedNovember 4, 2019
October 1, 2019
1.4 years
October 31, 2019
October 31, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in total body fat percentage loss versus bodyweight
week1; week16; week20
Study Arms (2)
Placebo
PLACEBO COMPARATORVerum
EXPERIMENTALSinetrol® Xpur
Interventions
Eligibility Criteria
You may qualify if:
- overweight or obese (25 kg.m-2\<BMI\<42.5kg.m-2)
- healthy
You may not qualify if:
- metabolic or chronical disease with treatments (i.e.: diabetes, dyslipidemia, thyroiditis, inflammatory disease, immunological disease, infectious disease, asthma, anxiety and depression)
- food allergy to the ingredients of the product (grapefruit, orange, caffeine, guarana)
- involved in the prior 6 months in a chronic treatment program, eating disorders history, subjected to weight reduction by surgery
- start or quit smoking, high alcohol consumption
- pregnant, breastfeeding, wanting to have a baby,
- menopausal women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fytexialead
Study Sites (1)
UCAM
Murcia, Spain
Related Publications (1)
Muralidharan J, Romain C, Martinez-Noguera FJ, Marin-Cascales E, Chung L, Alcaraz P, Cases J. A 16-week supplementation with a polyphenol-rich supplement, Sinetrol(R) Xpur, aids in fat loss of overweight and obese volunteers: a randomised, double-blind, parallel trial. Int J Food Sci Nutr. 2026 Feb;77(1):40-47. doi: 10.1080/09637486.2025.2589845. Epub 2025 Dec 15.
PMID: 41399165DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Pedro Alcaraz Ramon
UCAM
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 31, 2019
First Posted
November 4, 2019
Study Start
April 1, 2015
Primary Completion
September 1, 2016
Study Completion
September 1, 2017
Last Updated
November 4, 2019
Record last verified: 2019-10